VRDN · Viridian Therapeutics, Inc.\DE · Documents
$22.43
+1.63 (+7.84%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$2.46B
Shares
113.29M
Volume · Oct 20
1.97M
Avg daily vol (3M)
1.79M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-04-26 | 2021-04-23 | |
| 10-K | — | 2021-03-26 | 2020-12-31 | |
| 8-K | — | 2021-03-25 | — | |
| 8-K | — | 2021-01-20 | 2021-01-15 | |
| 8-K | — | 2021-01-04 | 2020-12-31 | |
| 8-K | — | 2020-12-17 | 2020-12-16 | |
| DEF 14A | — | 2020-12-14 | 2020-12-31 | |
| 8-K | — | 2020-12-09 | — | |
| 8-K | — | 2020-12-04 | 2020-12-02 | |
| 8-K | — | 2020-11-13 | 2020-11-12 | |
| 10-Q | — | 2020-11-12 | 2020-09-30 | |
| 8-K | — | 2020-11-10 | — | |
| 8-K | — | 2020-10-28 | 2020-10-27 | |
| 8-K | — | 2020-10-14 | 2020-10-08 | |
| 8-K | — | 2020-10-05 | — | |
| 8-K/A | — | 2020-10-01 | 2020-09-13 | |
| 8-K | — | 2020-09-17 | 2020-09-13 | |
| 8-K | — | 2020-08-20 | — | |
| 8-K | — | 2020-08-05 | — | |
| 10-Q | — | 2020-08-05 | 2020-06-30 | |
| 8-K | — | 2020-07-24 | 2020-07-23 | |
| 8-K | — | 2020-07-02 | — | |
| 8-K | — | 2020-06-23 | 2020-06-22 | |
| 8-K | — | 2020-06-19 | 2020-06-16 | |
| 8-K | — | 2020-05-22 | — | |
| 10-Q | — | 2020-05-08 | 2020-03-31 | |
| 8-K | — | 2020-05-07 | — | |
| 8-K | — | 2020-04-27 | — | |
| DEF 14A | — | 2020-04-10 | — | |
| 10-K | — | 2020-03-13 | 2019-12-31 | |
| 8-K | — | 2020-03-11 | — | |
| 8-K | — | 2020-02-19 | 2020-02-12 | |
| 8-K | — | 2020-02-07 | — | |
| 8-K | — | 2020-02-06 | — | |
| 8-K | — | 2020-01-30 | — |
Showing 101–135 of 135 filings
Key facts
CIK
1590750
CUSIP
92790C104
13F (30d)
10 filings
10 filers
Visit website
Investor relations